SCHEMBL8059445

SCHEMBL8059445

COC1CCc2c(C(=O)NC=NN)[nH]c3cccc1c23

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.37
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 1/20 0.35
MTNR1A P48039 4/20 0.33
MTNR1B P49286 4/20 0.33
HSD17B10 Q99714 3/20 0.32
HTR1A P08908 2/20 0.32
DRD2 P14416 2/20 0.32
HPGD P15428 2/20 0.32
MAPKAPK2 P49137 1/20 0.30
LMNA P02545 1/20 0.30
TSHR P16473 1/20 0.30
ACHE P22303 1/20 0.30
SIRT1 Q96EB6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059450 0.97 PARP1 (0.36) PARP1ALDH1A1KDM4EMAPTMTNR1A
SCHEMBL8070432 0.84 PARP1 (0.37) PARP1ALDH1A1KDM4EMAPTHTR1A
SCHEMBL8059441 0.81 PARP1 (0.39) PARP1ALDH1A1KDM4EMAPTMTNR1A
SCHEMBL8069960 0.81 BRD3 (0.38) PARP1KDM4EMAPTHTR1ADRD2
SCHEMBL8059448 0.80 PARP1 (0.36) PARP1ALDH1A1KDM4EMAPTMTNR1A
SCHEMBL8070004 0.74 PARP1 (0.48) PARP1ALDH1A1KDM4EMAPTDRD2
SCHEMBL8069953 0.74 MCL1 (0.40) PARP1ALDH1A1KDM4EMAPTHPGD
SCHEMBL8073394 0.73 PARP1 (0.47) PARP1ALDH1A1KDM4EMAPTDRD2
SCHEMBL8068502 0.72 PARP1 (0.37) PARP1ALDH1A1KDM4EMAPT
SCHEMBL8070430 0.72 PARP1 (0.36) PARP1ALDH1A1KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0803501-B1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors SUMITOMO PHARMA (JP) 2000-07-05 EP disclosed
EP-0803501-A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-10-29 EP disclosed